VC Fund
🇪🇺 Abingworth Bioventures VI
Abingworth LLP · Multi-Country
Fund size
USD 375 million
Focus
Health & Bio
EIF sector
Life Science
About Abingworth Bioventures VI
Abingworth Bioventures VI is a life sciences venture capital fund managed by Abingworth LLP, a London-based investor specialising in biotech and healthcare. The 2012-vintage fund closed in 2014 at USD 375 million and invests across Europe and the US, writing tickets of roughly USD 8-30 million per company. Portfolio companies have included Verona Pharma and Vaxcyte.
EUACC IntelligenceFree preview
EUACC Intelligence
Ask about Abingworth Bioventures VI
Get instant answers about Abingworth Bioventures VI and how it fits your raise.